Trademark search for Jeffrey J. Ellison · TMDB

Compare trademarks

Class(es)

5

Philip E Wolfson MD APC

03/07/2022

-

03/07/2032

10

01/20/2022

-

01/20/2032

542

10/19/2021

-

10/19/2031

HYALEX ORTHOPAEDICS

1

HYALEX ORTHOPAEDICS, INC.

04/28/2021

-

04/28/2031

1

HYALEX ORTHOPAEDICS, INC.

04/26/2021

-

04/26/2031

1644

Marius Pharmaceuticals, LLC

12/08/2021

-

12/08/2031

ADEQUATE TESTOSTERONE THERAPY

1644

Marius Pharmaceuticals, LLC

07/22/2021

-

03/03/2022

5

Corbus Pharmaceuticals, Inc.

04/12/2019

-

11/02/2020

THE THOMAS CROWN COLLECTION

14

10/30/2013

-

-

ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

THE THOMAS CROWN COLLECTION

14

10/09/2013

-

-

ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

That’s Why a Free TMDB Account Is Worthwhile

Monitor and protect brands

If you have set up trademark monitoring, you will automatically receive an email about copycats and free riders. This is how uncomplicated real-time brand protection works.

Follow brands easily

If you follow a trade mark, you will receive an e-mail when new applications, oppositions, deadlines, renewals and much more are filed. - This way, you can stay up to date on the development of a trade mark.

Sign up for free

9354144

Aegerion Pharmaceuticals, Inc.

03/28/2014

08/29/2017

-

REGISTERED

944

Aegerion Pharmaceuticals, Inc.

03/28/2014

-

-

ABANDONED - NO STATEMENT OF USE FILED

93841

Aegerion Pharmaceuticals, Inc.

03/28/2014

-

-

ABANDONED - NO STATEMENT OF USE FILED

94144

Aegerion Pharmaceuticals, Inc.

03/28/2014

-

-

ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

944

Aegerion Pharmaceuticals, Inc.

03/28/2014

-

-

ABANDONED - NO STATEMENT OF USE FILED

JUXTALKING ABOUT

944

Aegerion Pharmaceuticals, Inc.

03/28/2014

-

-

ABANDONED - NO STATEMENT OF USE FILED

JUXRIGHT NUTRITIONAL PLAN

94144

Aegerion Pharmaceuticals, Inc.

03/28/2014

-

-

ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

944

Aegerion Pharmaceuticals, Inc.

03/28/2014

-

-

ABANDONED - NO STATEMENT OF USE FILED

A CHANCE TO GET TO A NEW LEVEL

94144

Aegerion Pharmaceuticals, Inc.

03/28/2014

-

-

ABANDONED - NO STATEMENT OF USE FILED

5

Corbus Pharmaceuticals, Inc.

07/30/2020

-

-

NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER

5

Corbus Pharmaceuticals, Inc.

07/30/2020

-

-

NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER

5

Corbus Pharmaceuticals, Inc.

07/30/2020

-

-

NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER

5

Corbus Pharmaceuticals, Inc.

07/30/2020

-

-

NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER

4244

Marius Pharmaceuticals, LLC

06/02/2020

-

-

PUBLICATION/ISSUE REVIEW COMPLETE

5

Marius Pharmaceuticals LLC

03/09/2020

-

-

PUBLICATION/ISSUE REVIEW COMPLETE

5

SynAgile Corporation

05/07/2019

-

-

FIRST EXTENSION - GRANTED

5

Corbus Pharmaceuticals, Inc.

04/11/2019

-

-

FIRST EXTENSION - GRANTED

5

Philip E Wolfson MD APC

09/12/2017

-

-

FIFTH EXTENSION - GRANTED

5

Philip E Wolfson MD APC

09/12/2017

-

-

FIFTH EXTENSION - GRANTED

5

Corbus Pharmaceuticals, Inc.

07/27/2017

-

-

ABANDONED - NO STATEMENT OF USE FILED

5

Corbus Pharmaceuticals, Inc.

01/24/2017

-

-

ABANDONED - NO STATEMENT OF USE FILED

10

Cerapedics, Inc.

08/30/2016

-

-

ABANDONED - NO STATEMENT OF USE FILED

5

08/03/2016

-

-

ABANDONED - NO STATEMENT OF USE FILED

5

07/11/2016

02/18/2020

-

REGISTERED

1

HYALEX ORTHOPAEDICS, INC.

01/09/2016

09/10/2019

-

REGISTERED

44

Corbus Pharmaceuticals, Inc.

08/12/2015

11/19/2019

-

REGISTERED

CORBUS PHARMACEUTICALS

5

Corbus Pharmaceuticals, Inc.

08/12/2015

07/30/2019

-

REGISTERED

CORBUS PHARMACEUTICALS

44

Corbus Pharmaceuticals, Inc.

08/12/2015

09/27/2016

-

REGISTERED

10

HYALEX ORTHOPAEDICS, INC.

11/04/2011

07/22/2014

-

REGISTERED

42

Synagile Corporation

07/28/2011

10/16/2012

-

SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

Search results 1 - 41 of 44

We love brands.
And are happy to look after you.

You can reach us from Monday to Friday between 08:00-16:00.

Kontaktieren Sie uns.